Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Gang Wu

ResearcherPublications, citations & collaboration network

Gang Wu is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 328 works, 8,024 citations, an h-index of 40 and an i10-index of 108.

328
Works
8,024
Citations
40
h-index
108
i10-index

How has Gang Wu's publication output changed over time?

ScholarIQpublication output · 2012–2021

Output grew100% over the shown period — from 1 works in 2012 to 2 in 2021.

1
2
2
1
1
2
2
2012201520172018201920202021

What are the most-cited papers on Gang Wu?

ScholarIQmost cited works
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
Yi‐Long Wu, Caicun Zhou, Chong Kin Liam, Gang Wu, Xuan Liu, Zhaoyang Zhong, Shun Lü, Ying Cheng, Baohui Han, Lin Chen, Cheng Huang, Shanshan Qin, Yixiang Zhu, Hui Pan, Houjie Liang, Elizabeth Li, Guangliang Jiang, Soon Hin How, Mitchel Fernando, Y. Zhang, Fan Xia, Yanchen Zuo
Annals of Oncology. 2015738 Citations
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang, Yuhan Sheng, Chaolin Huang, Yang Jin, Nian Xiong, Ke Jiang, Hongda Lu, Jing Liu, Jiyuan Yang, Youhong Dong, Dongfeng Pan, Chengrong Shu, Jun Li, Jielin Wei, Yu Huang, Ling Peng, Mengjiao Wu, Ruiguang Zhang, Bian Wu, Yuhui Li, Liqiong Cai, Guiling Li, Tao� Zhang, Gang Wu
The Lancet Oncology. 2020602 CitationsOPEN ACCESS
Household transmission of SARS-CoV-2
Zhongliang Wang, Wan‐Li Ma, Xin Zheng, Gang Wu, Ruiguang Zhang
S19579164. 2020253 CitationsOPEN ACCESS

Related on ScholarIQ

Hubei University of Chinese Medicine
Institution
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis
Paper
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
Paper
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma
Paper
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Paper
Household transmission of SARS-CoV-2
Paper
470M+ articles · free account